Scott Kapnick 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 07:54 am Sale |
2022-12-31 | 13G | Aileron Therapeutics, Inc. ALRN |
Scott Kapnick | 379,608 8.400% |
-3 (-0.00%) |
Filing |
| 2022-02-14 09:02 am Purchase |
2021-12-31 | 13G | Aileron Therapeutics, Inc. ALRN |
Scott Kapnick | 18,981 8.400% |
10,538 (+124.81%) |
Filing |